CPHI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CPHI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The historical data trend for China Pharma Holding's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Pharma Holding Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Shiller PE Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
China Pharma Holding Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Shiller PE Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where China Pharma Holding's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
China Pharma Holding's E10 for the quarter that ended in Dec. 2023 is calculated as:
For example, China Pharma Holding's adjusted earnings per share data for the three months ended in Dec. 2023 was:
Adj_EPS | = | Earnings per Share (Diluted) | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | -0.116 | / | 114.6694 | * | 114.6694 | |
= | -0.116 |
Current CPI (Dec. 2023) = 114.6694.
China Pharma Holding Quarterly Data
Earnings per Share (Diluted) | CPI | Adj_EPS | |
201403 | -2.500 | 98.600 | -2.907 |
201406 | -10.000 | 98.200 | -11.677 |
201409 | -7.500 | 98.900 | -8.696 |
201412 | -25.500 | 99.000 | -29.536 |
201503 | -4.500 | 99.900 | -5.165 |
201506 | 1.500 | 99.500 | 1.729 |
201509 | 3.500 | 100.500 | 3.993 |
201512 | -7.000 | 100.600 | -7.979 |
201603 | -2.000 | 102.200 | -2.244 |
201606 | -3.000 | 101.400 | -3.393 |
201609 | -2.000 | 102.400 | -2.240 |
201612 | -4.000 | 102.600 | -4.471 |
201703 | -1.000 | 103.200 | -1.111 |
201706 | -2.500 | 103.100 | -2.781 |
201709 | -2.500 | 104.100 | -2.754 |
201712 | -15.500 | 104.500 | -17.008 |
201803 | -0.500 | 105.300 | -0.544 |
201806 | -1.000 | 104.900 | -1.093 |
201809 | -2.000 | 106.600 | -2.151 |
201812 | -9.000 | 106.500 | -9.690 |
201903 | -0.500 | 107.700 | -0.532 |
201906 | -1.000 | 107.700 | -1.065 |
201909 | -1.000 | 109.800 | -1.044 |
201912 | -22.000 | 111.200 | -22.686 |
202003 | -1.000 | 112.300 | -1.021 |
202006 | 0.015 | 110.400 | 0.016 |
202009 | -1.000 | 111.700 | -1.027 |
202012 | -1.500 | 111.500 | -1.543 |
202103 | -1.000 | 112.662 | -1.018 |
202106 | -1.000 | 111.769 | -1.026 |
202109 | -1.000 | 112.215 | -1.022 |
202112 | -1.200 | 113.108 | -1.217 |
202203 | -1.100 | 114.335 | -1.103 |
202206 | -0.900 | 114.558 | -0.901 |
202209 | -0.800 | 115.339 | -0.795 |
202212 | -0.980 | 115.116 | -0.976 |
202303 | -0.300 | 115.116 | -0.299 |
202306 | -0.300 | 114.558 | -0.300 |
202309 | -0.300 | 115.339 | -0.298 |
202312 | -0.116 | 114.669 | -0.116 |
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
China Pharma Holding (OTCPK:CPHI) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Thank you for viewing the detailed overview of China Pharma Holding's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Ke Deng | 10 percent owner | NO.17, JINPAN ROAD, SECOND FLOOR, HAIKOU F4 570216 |
Frank Waung | officer: Chief Financial Officer | 72 GREAT HILLS RD., SHORT HILLS NJ 07078 |
G Michael Bennett | director | 4/F, NO. 3 JINYUAN ROAD, DAXING DISTRICT INDUSTRIAL DEVELOPMENT A, BEIJING F4 102600 |
Yingwen Zhang | director | NO. 5, UNIT 1, BLDG. 4, NO. 14 XIN NAN ZHI RD., CHENGDU, SICHUAN F4 610041 |
Baowen Dong | director | NO.9, BLDG. 9, SOUTH PARK, NO. 24, SECTION 1, 1ST RING ROAD, CHENGDU, SICHUAN F4 610041 |
Heung Mei Tsui | director, 10 percent owner | FLAT F, 3RD FL., MAYSON GARDEN BLDG., 68 HING FAT ST., CAUSEWAY BAY, HONG KONG F4 XXXXX |
Zhilin Li | officer: President and CEO | 2/F JIAHAI BLDG., NO. 17 JINPAN ROAD, JINPAN INDUSTRY DEVELOPMENT, HAIKOU, HAINAN PROVINCE F4 570216 |
Jian Yang | officer: Secretary | NO. 1 HAOYUAN ROAD, XINHUA DISTRICT, HAIKOU, HAINAN PROVI F4 570216 |
Xinhua Wu | officer: CFO | 2/F JIAHAI BLDG., NO. 17 JINPAN ROAD, JINPAN INDUSTRY DEVELOPMENT, HAIKOU, HAINAN PROVI F4 570216 |
George L Diamond | 10 percent owner | 174 FM 1830, ARGYLE TX 76226 |
David F Brigante | 10 percent owner | 174FM 1830, ARGYLE TX 76226 |
Marat Rosenberg | 10 percent owner | 17 FM 1830, ARGYLE TX 76226 |
Halter Financial Investments Lp | 10 percent owner | 174 FM 1830, ARGYLE TX 76226 |
Halter Financial Investments Gp Llc | 10 percent owner | 174 FM 1830, ARGYLE TX 76226 |
Timothy P Halter | director, 10 percent owner, officer: CEO, President & CFO | 174 FM 1830, ARGYLE TX 76226 |
From GuruFocus
By PRNewswire PRNewswire • 02-24-2023
By PRNewswire PRNewswire • 03-13-2020
By PRNewswire PRNewswire • 08-13-2021
By PRNewswire PRNewswire • 11-15-2018
By GuruFocus Research • 08-23-2023
By PRNewswire PRNewswire • 12-05-2022
By PRNewswire PRNewswire • 12-28-2022
By PRNewswire PRNewswire • 11-13-2018
By PRNewswire PRNewswire • 12-15-2022
By PRNewswire PRNewswire • 07-02-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.